Basel is Europe’s number one life sciences supercluster and is home to over 800 companies, including Roche and Novartis. It dominates Swiss biotech investment and is the global leader in pharmaceutical R&D and trinational innovation.

                                                                  

As a global hub for health and business, Basel has established a distinctive tech community where artificial intelligence (AI), state-of-the-art software and next-generation supercomputers are being employed to accelerate medical breakthroughs and transform the way global companies operate.

Scientific Specialists

A significant part of Basel’s ICT expertise lies at the intersection of technology and life sciences. Companies in this category provide the advanced data processing, automation and algorithmic capabilities required by modern medicine.

Genedata is a prime example, developing enterprise-grade bioinformatics software that forms the digital backbone for genomic data and pharmaceutical R&D workflows worldwide.

The Future-Tech Infrastructure

Basel is not only optimising today's technology, but also investing in the computing infrastructure of tomorrow to solve the next generation of complex industrial and scientific challenges.

QuantumBasel is leading the way as Switzerland's premier hub for Quantum Computing as a Service (QCaaS), translating quantum theory into practical applications for molecular design, logistics and advanced machine learning.

The pure-play tech outliers

Proving that Basel’s tech talent isn’t exclusively tied to healthcare, the region successfully breeds world-class software companies that compete globally in entirely different industries, such as media, marketing and enterprise commerce.

Featured example is Magnolia, a global pioneer in Enterprise Content Management Systems (ECMS) and Digital Experience Platforms (DXP), championing modern 'headless' web architecture for major international brands.

The Ecosystem Catalysts

To ensure a continuous flow of fresh talent, ideas and technology into the region, Basel relies on dedicated economic and innovation frameworks.

For exmaple, DayOne acts as the region's ultimate matchmaker and start-up accelerator, bridging the gap between young digital health innovators and established corporate giants.

BioTechX connects every vertical across the entire biotech and pharmaceutical ecosystem – drug discovery, clinical trials, R&D, data science, tech pioneers, investors, and pharma leaders - with a focus on innovation, data integration, and accelerating drug development.

6 – 8 October 2026

                                                                     

While other regions focus on autonomous drones or industrial robotics, Basel has established a world-class, highly specialised niche in: Medical Robotics and Lab Automation. Basel is deeply integrated into Europe’s number one life sciences supercluster, where high-precision engineering meets the future of healthcare. The city is the global epicentre for technologies that are transforming the operating theatre and the pharmaceutical laboratory.